Leslie Trigg - 26 Jun 2026 Form 4 Insider Report for Outset Medical, Inc. (OM)

Reporting relationship: Chair and CEO, Director
Issuer ticker: OM
Reported as of: 26 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jun 2026, 19:13:19 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: John Brottem For: Leslie Trigg

Key filing fact

Leslie Trigg filed Form 4 for Outset Medical, Inc. (OM) on 29 Jun 2026.

Key facts

This page summarizes Leslie Trigg's Form 4 filing for Outset Medical, Inc. (OM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 19:13.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001304125 Primary reporting owner

Trigg Leslie

Relationship: Chair and CEO, Director
Address: 3052 ORCHARD DRIVE, SAN JOSE
Signature: John Brottem For: Leslie Trigg
Signature date: 29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Award

Transaction value
Shares: +99,160
Change %: +100%
Price: $0.000000^*
Shares after: 198,034
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1

OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 41,666
Date: 26 Jun 2026
Ownership: Trigg 2002 Rev Trust

OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 584
Date: 26 Jun 2026
Ownership: Trigg Family Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.